Literature DB >> 10372268

Epidemiology and the natural course of inflammatory bowel disease.

P G Andres1, L S Friedman.   

Abstract

Ulcerative colitis and Crohn's disease are inflammatory disorders of the gastrointestinal tract that are distributed unevenly within populations and throughout the world. Although the exact causes of inflammatory bowel disease (IBD) remain unknown, study of the epidemiology of IBD has provided insight into pathogenesis. This article examines the geographic, ethnic, and other trends of IBD; risk factors (including genetic and environmental); and the natural history of IBD.

Entities:  

Mesh：

Year:  1999        PMID： 10372268     DOI： 10.1016/s0889-8553(05)70056-x

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN： 0889-8553            Impact factor:   3.806


  64 in total

1.  p53 antibodies, metallothioneins, and oxidative stress markers in chronic ulcerative colitis with dysplasia.

Authors:  Hala E Hamouda; Soha S Zakaria; Saber A Ismail; Mahmoud A Khedr; Wael W Mayah
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

Review 2.  Have genomic discoveries in inflammatory bowel disease translated into clinical progress?

Authors:  Adam V Weizman; Mark S Silverberg
Journal:  Curr Gastroenterol Rep       Date:  2012-04

Review 3.  Fertility and pregnancy in the patient with inflammatory bowel disease.

Authors:  U Mahadevan
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

Review 4.  Wound healing and fibrosis in intestinal disease.

Authors:  F Rieder; J Brenmoehl; S Leeb; J Schölmerich; G Rogler
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

Review 5.  Genetics of inflammatory bowel disease: current status and future directions.

Authors:  Thomas D Walters; Mark S Silverberg
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

Review 6.  Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions.

Authors:  Lena Ohman; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-01-26       Impact factor: 46.802

7.  Changes in trabecular bone density in incident pediatric Crohn's disease: a comparison of imaging methods.

Authors:  A Tsampalieros; M K Berkenstock; B S Zemel; L Griffin; J Shults; J M Burnham; R N Baldassano; M B Leonard
Journal:  Osteoporos Int       Date:  2014-04-24       Impact factor: 4.507

8.  Use of complementary medicine in pediatric patients with inflammatory bowel disease: results from a multicenter survey.

Authors:  Anthony P Wong; Ann L Clark; Elizabeth A Garnett; Michael Acree; Stanley A Cohen; George D Ferry; Melvin B Heyman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-01       Impact factor: 2.839

9.  Novel Rho/MRTF/SRF inhibitors block matrix-stiffness and TGF-β-induced fibrogenesis in human colonic myofibroblasts.

Authors:  Laura A Johnson; Eva S Rodansky; Andrew J Haak; Scott D Larsen; Richard R Neubig; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325

10.  Medical treatment of ulcerative colitis.

Authors:  Uma Mahadevan
Journal:  Clin Colon Rectal Surg       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.